Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses

International Journal of Clinical Pharmacology and Therapeutics

Volumn 40, Issue 5, 2002, Pages 213-220

  Stockis, A ^a   Allemon, A M ^a   De Bruyn, S ^a   Gengler, C ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Antiprotozoal; Glucuronide; Nitazoxanide; Pharmacokinetics; Tizoxanide

Indexed keywords

ANTIPARASITIC AGENT; NITAZOXANIDE; PLACEBO; TIZOXANIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG SOLUBILITY; DRUG TOLERABILITY; DRUG TRANSPORT; ELECTROCARDIOGRAPHY; FOOD DRUG INTERACTION; FOOD INTAKE; GASTROINTESTINAL DISEASE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 0036246883     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40213     Document Type: Article

References (26)

1. Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: A report on 546 patients in Egypt
2. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model
3. Nitazoxanide: Pharmacokinetics and metabolism in man
4. Étude de diverses associations d'anthelminthiques chez la souris
5. Interaction of nitazoxanide and its desacetyl metabolite tizoxanide with human cytochrome P450 isoforms
6. Screening of compounds for antimicrosporidial activity in vitro
7. Sample size determination: Extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43
8. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa
9. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms
10. Expérimentation des propriétés anthelminthiques de la nitazoxanide chez le chien, le chat et les ovins
11. The Design and Analysis of Clinical Experiments
12. Categorical data analysis
13. Nitazoxanide, a potential drug to eradicate Helicobacter pylori with no cross-resistance to metronidazole
14. Pre-clinical toxicology of nitazoxanide - A new antiparasitic compound
15. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico
16. New derivatives of 2-benzamido 5-nitrothiazoles
17. Nitazoxanide in the treatment of Taenia saginata and Hymenolepsis nana infections
18. Successful treatment of heavily infected human fascioliasis with nitazoxanide: A case report
19. A double-blind placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhea in AIDS patients in Mexico
20. Synthesis and antibacterial activities of tizoxanide, an N-(nitrothiazolyl)salicylamide, and its O-aryl glucuronide
21. Update on the statistical analysis of bioequivalence studies
22. Lack of pharmacokinetic interaction as equivalence problem
23. Pharmacokinetics of nitazoxanide after single dose oral administration in 6 healthy volunteers
24. The efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models